[1]
H. Mahmud, A. N. M. A. Hai, and T. Ahammod, “Effect of spironolactone with angiotensin receptor blocker on albuminuria in type 2 diabetic patients with nephropathy”, Int J Adv Med, vol. 9, no. 4, pp. 393–398, Mar. 2022.